Evaluating the Economic and Societal Challenges of Diabetic Retinopathy and Diabetic Macular Edema




Date:               Thursday, May 2, 2019

Location:         Wynn and Encore Hotels
3131 S Las Vegas Boulevard
Las Vegas, Nevada 89109

Room: Lafleur

Time:               7:00 am – 8:30 am
                        *Breakfast will be available
 

Program Description
Diabetic macular edema (DME) is a leading cause of vision loss and blindness. Medical costs have been estimated to be about 31% higher over a 1-year period and 29% higher over a 3-year period in Medicare patients with untreated DME compared with unaffected patients with diabetes. Intravitreal antivascular endothelial growth factor inhibitors are recommended to reduce the risk of vision loss. Specialty pharmacists are integral members of a patient’s health care team and have a significant impact on the care and management of patients with DME. Additionally, these health care professionals may be closely involved in formulary design and agent substitution, which may decrease health care utilization and improve clinical outcomes in patients with DME.

Educational Objectives
  • Examine diabetic retinopathy and macular edema, including prevalence, pathophysiology, and social and economic burden of disease on patients’ quality of life
  • Identify current and emerging treatment options for diabetic macular edema
  • Explore how managed care pharmacists can contribute to the management of this disease in order to minimize disease burden 

Faculty Presenter

Eric Cannon, PharmD, FAMCP
Vice President, Pharmacy Benefits
SelectHealth
Murray, Utah

Daniel Kiernan, MD, FACS
Ophthalmologist and Vitreoretinal Surgeon
Ophthalmic Consultants of Long Island
Rockville Centre, New York

This activity is supported by an educational grant from Genentech.

Accreditation
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-19-053-L01-P. The activity is available for CE credit for May 2, 2019.

Obtaining Credit:
All participants who attended the live symposium need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Detailed instructions on obtaining credit will be provided at the session. Credit must be requested no later than July 2, 2019.